NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDR) — FDA Approval ANDA074736 (WATSON
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDR) — FDA Approval ANDA074736 (WATSON is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE; Active ingredients: NALOXONE HYDROCHLORIDE; PENTA
| Brand name | NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE |
|---|---|
| Active ingredients | NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE |
| Application number | ANDA074736 |
| Sponsor | WATSON LABS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 19970121 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →